Skip to content

Lipids and Diabetes-Related Complications in Type 2 Diabetes

Lipids and Diabetes-Related Complications in Type 2 Diabetes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122765
Enrollment
Unknown
Registered
2026-04-17
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

patients with diabetes:None

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with diabetes based on any of the following criteria: a. Glycated hemoglobin (HbA1c) = 6.5% b. Fasting plasma glucose (FPG) = 7.0 mmol/L c. 2-hour plasma glucose = 11.1 mmol/L during an oral glucose tolerance test (OGTT) d. Random plasma glucose = 11.1 mmol/L with classic hyperglycemic symptoms (e.g., polyuria, polydipsia, weight loss) e. Documented diagnosis of diabetes in medical records f. Current use of glucose-lowering medications (2) Age = 18 years; (3) Complete data on key covariates, including cholesterol levels, HbA1c, lipid-lowering therapy, and body mass index (BMI).

Exclusion criteria

Exclusion criteria: (1) Age < 18 years; (2) Incomplete clinical data; (3) Patients with acute complications.

Design outcomes

Primary

MeasureTime frame
Low-Density Lipoprotein Cholesterol;Remnant Cholesterol;

Secondary

MeasureTime frame
Total Cholesterol;High-Density Lipoprotein Cholesterol;Triglyceride;Non-High-Density Lipoprotein Cholesterol;

Countries

China

Contacts

Public ContactTingting Du

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

dutt@hust.edu.cn+86 27 8366 5513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026